Scott A Hubers

5PUBLICATIONS
13CO-AUTHORS
Respiratory diseasesBiologically active moleculesCardiology (incl. cardiovascular diseases)Computational physiologyPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 08, 2024
Renal Effects of Combination Phosphodiesterase V Inhibition and Low-Dose B-Type Natriuretic Peptide in Acute Heart Failure: A Randomized Clinical Trial.

Scott A Hubers, Sherry L Benike, Bradley K Johnson

|Jan 20, 2022
DPP4 (Dipeptidyl Peptidase-4) Inhibition Increases Catecholamines Without Increasing Blood Pressure During Sustained ACE (Angiotensin-Converting Enzyme) Inhibitor Treatment.

Jessica R Wilson, Erica M Garner, Mona Mashayekhi

|Jan 10, 2022
Cardiorenal Effects of Long-Term Phosphodiesterase V Inhibition in Pre-Heart Failure.

Scott A Hubers, Siu-Hin Wan, Fadi W Adel

|Aug 05, 2020
B-type natriuretic peptide and cardiac remodelling after myocardial infarction: a randomised trial.

Scott A Hubers, John A Schirger, S Jeson Sangaralingham

|Sep 19, 2019
Dipeptidyl Peptidase 4 Inhibition Increases Postprandial Norepinephrine via Substance P (NK1 Receptor) During RAAS Inhibition.

Jessica R Wilson, Scott Jafarian Kerman, Scott A Hubers

Pageof 1

Frequent Collaborators

2 joint publications

Jessica R Wilson

2 joint publications

Scott Jafarian Kerman

2 joint publications

Nancy J Brown

2 joint publications

Christopher Scott